Vir Biotechnology, Inc. (VIR)
NASDAQ
11.70
+0.58 (+5.22%)
Closed
Oct 9, 2026
Day's Range
11.0411.96
52 wk Range
4.8211.96
Financial Statements - VIR - Vir Biotechnology, Inc.
Revenue
66.52M▲ 4.4%
Net Income
-437.98M▲ 16.1%Net Margin -658.4%
EBITDA
-469.74M▲ 5.5%
Free Cash Flow
-396.61M▲ 12.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 66.52M | 63.71M | 39.49M | 1.58B | 1.08B | 67.24M |
| Cost of Goods | 26K | 845K | 2.76M | 146.31M | 65.86M | 0 |
| Gross Profit | 66.49M | 62.86M | 36.72M | 1.43B | 1.02B | 67.24M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -479.51M | -552.17M | -684.30M | 833.06M | 420.75M | -296.98M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 1.50M | -42.74M | -30.87M | -106.88M | 128.61M | -4.46M |
| Pre Tax Income | -437.77M | -523.10M | -628.19M | 754.28M | 549.80M | -298.61M |
| Income Tax | 217K | -1.14M | -13.07M | 238.44M | 21.21M | 54K |
| Net Income | -437.98M | -521.96M | -615.11M | 515.83M | 528.58M | -298.66M |
| EPS Basic | -3.16 | -3.83 | -4.59 | 3.89 | 4.07 | -2.51 |
| EPS Diluted | -3.16 | -3.83 | -4.59 | 3.83 | 3.96 | -2.51 |
| Basic Shares Outstanding | 138.52M | 136.24M | 134.13M | 132.60M | 129.88M | 119.15M |
| Diluted Shares Outstanding | 138.52M | 136.24M | 134.13M | 132.60M | 129.88M | 119.15M |
| Ebit | -479.51M | -552.17M | -684.30M | 833.06M | 420.75M | -296.98M |
| Ebitda | -469.74M | -497.08M | -642.96M | 950.99M | 288.51M | -291.53M |
| Net Income Continuous Operations | -437.98M | -521.96M | -615.11M | 515.83M | 528.58M | -298.66M |
| Minority Interests | 0 | 0 | 56K | 0 | 0 | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
